BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 18078869)

  • 1. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
    Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
    Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
    Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
    Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
    Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function.
    Gillberg P; Bramnert M; Thorén M; Werner S; Johannsson G
    Growth Horm IGF Res; 2001 Oct; 11(5):273-81. PubMed ID: 11735245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reduction in visceral fat mass in response to growth hormone is more marked in men than in oestrogen-deficient women.
    Franco C; Koranyi J; Brandberg J; Lönn L; Bengtsson BK; Svensson J; Johannsson G
    Growth Horm IGF Res; 2009 Apr; 19(2):112-20. PubMed ID: 18752977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency].
    Olsovská V; Siprová H; Beránek M; Soska V
    Vnitr Lek; 2005 Dec; 51(12):1356-64. PubMed ID: 16430102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of growth hormone therapy on intermediary metabolism and insulin sensitivity in hypopituitary adults.
    Johnston DG; Al-Shoumer KA; Chrisoulidou A; Kousta E; Beshyah S; Robinson S
    J Endocrinol Invest; 1999; 22(5 Suppl):37-40. PubMed ID: 10442569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy.
    Perotti M; Caumo A; Brunani A; Cambiaghi N; Casati M; Scacchi M; Perra S; Rocco C; Mancia G; Grassi G; Cavagnini F; Pincelli AI
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):721-7. PubMed ID: 22519803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.
    Svensson J; Mattsson A; Rosén T; Wirén L; Johannsson G; Bengtsson BA; Koltowska Häggström M;
    Growth Horm IGF Res; 2004 Jun; 14(3):207-15. PubMed ID: 15125882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
    Sverrisdóttir YB; Elam M; Caidahl K; Söderling AS; Herlitz H; Johannsson G
    J Hypertens; 2003 Oct; 21(10):1905-14. PubMed ID: 14508197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.
    Hana V; Silha JV; Justova V; Lacinova Z; Stepan JJ; Murphy LJ
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):442-50. PubMed ID: 15049958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B; Kann PH
    Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma total homocysteine concentrations in adults with growth hormone (GH) deficiency: effects of GH replacement.
    Lewandowski KC; Murray RD; Drzewoski J; O'Callaghan CJ; Czupryniak L; Hillhouse EW; Shalet SM; Randeva HS
    Mol Genet Metab; 2003 Nov; 80(3):330-7. PubMed ID: 14680980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.